Literature DB >> 9754811

Changes in the galactose content of IgG during humoral immune responses.

G C Lastra1, S J Thompson, A S Lemonidis, C J Elson.   

Abstract

The Fc region of IgG bears two oligosaccharides of variable composition. The serum level of one variant which lacks terminal galactose and sialic acid (agalactosyl IgG) is raised in a number of autoimmune diseases and animal models thereof. Here it is shown that such changes in IgG glycosylation occur during non-pathological humoral immune responses. It was found that if specific pathogen free (SPF) CBA/Ca mice are transferred from a sterile to a conventional environment, their levels of total serum IgG rise whereas the degree of IgG galactosylation falls. Next, mice were immunised with bovine serum albumin (BSA) in incomplete Freund's adjuvant. As anti-BSA titres rose the antibodies became less galactosylated and later, as the titres fell, the antibodies became more galactosylated. By contrast, there was little or no variation in the relative galactosylation of total IgG. It is considered that the galactosylation of IgG antibodies varies during an immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754811     DOI: 10.3109/08916939808993842

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  11 in total

1.  The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G.

Authors:  P Jeddi; J Keusch; P M Lydyard; K B Bodman-Smith; M S Chesnutt; D Wofsy; H Hirota; T Taga; P J Delves
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

2.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

3.  Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia.

Authors:  R N Barker; R D Young; K A Leader; C J Elson
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

4.  Conference report: "Functional Glycomics in HIV Type 1 Vaccine Design" workshop report, Bethesda, Maryland, April 30-May 1, 2012.

Authors:  Angela Malaspina; Brenda S Collins; Anne Dell; Galit Alter; Thandi M Onami
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-19       Impact factor: 2.205

5.  Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis.

Authors:  Anand S Mehta; Ronald E Long; Mary Ann Comunale; Mengjun Wang; Lucy Rodemich; Jonathan Krakover; Ramila Philip; Jorge A Marrero; Raymond A Dwek; Timothy M Block
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

6.  Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposure.

Authors:  Songming Chen; Chen Lu; Hongbo Gu; Anand Mehta; Jianwei Li; Patrick B Romano; David Horn; D Craig Hooper; Carthene R Bazemore-Walker; Timothy Block
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

7.  Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.

Authors:  Maurice H J Selman; Sanne E de Jong; Darius Soonawala; Frank P Kroon; Ayola Akim Adegnika; André M Deelder; Cornelis H Hokke; Maria Yazdanbakhsh; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2011-12-19       Impact factor: 5.911

8.  A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.

Authors:  Anne Cathrine Vestrheim; Anders Moen; Wolfgang Egge-Jacobsen; Leon Reubsaet; Trine Grønhaug Halvorsen; Diane Bryant Bratlie; Berit Smestad Paulsen; Terje Einar Michaelsen
Journal:  Immun Inflamm Dis       Date:  2014-05-22

9.  Autoantibodies targeting tumor-associated antigens in metastatic cancer: Sialylated IgGs as candidate anti-inflammatory antibodies.

Authors:  Martin Oaks; Samuel Taylor; James Shaffer
Journal:  Oncoimmunology       Date:  2013-05-07       Impact factor: 8.110

Review 10.  Antibody glycosylation in inflammation, disease and vaccination.

Authors:  Galit Alter; Tom H M Ottenhoff; Simone A Joosten
Journal:  Semin Immunol       Date:  2018-06-11       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.